Sito Bio
30058311.842.96% ( +0.34 )
Sito Bio (300583)
Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9a-hydroxyandrost, 17a-hydroxy...
- Open
- 11.61
- High
- 11.84
- Low
- 11.36
- Prev. Close
- 11.50
- Volume
- 28.36K
- Turnover
- 33.17M
- Avg Price
- 11.70
- Bid/Ask Ratio
- -10.96%
- Amplitude
- 4.17%
- 52wk High
- 19.38
- Volume Ratio
- 0.60
- Turnover Ratio
- 1.50%
Sito Bio Analyst Rating
View MoreForecast & Rating
Apr 29, 2024Price forecast
--100.00%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- London Stock Exchange · Jul 28 at 05:06 AM
REG - GSK PLC - Hansoh positive 2nd Phase III results for Riz-Rez
- 36Kr · Mar 9 at 03:08 AM
Sito Bio: Plans to repurchase company shares for 15 million to 30 million yuan
- Zhitong · Nov 3, 2025 at 02:57 AM
Sito Bio: The listing application for the chemical raw material drug Methylprednisolone has been approved
- Zhitong · Oct 28, 2025 at 03:42 AM
Sito Bio released its performance for the first three quarters, with a net loss attributable to the parent company of 69.2303 million yuan
- Zhitong · Oct 9, 2025 at 06:45 AM
Sito Bio: Subsidiary Srey Pharmaceuticals received the CEP certificate for Dexamethasone Sodium Phosphate raw materials
- Zhitong · Aug 25, 2025 at 06:47 AM
Sito Bio released its performance for the first half of the year, turning from profit to a loss of 52.6871 million yuan
